dc.contributor.author | Pezaro, CJ | |
dc.contributor.author | Omlin, A | |
dc.contributor.author | Mastris, K | |
dc.contributor.author | ANZUP Consumer Advisory Panel, | |
dc.contributor.author | Attard, G | |
dc.contributor.author | Beer, TM | |
dc.contributor.author | Chi, KN | |
dc.contributor.author | Chowdhury, S | |
dc.contributor.author | Davis, ID | |
dc.contributor.author | Drake, CG | |
dc.contributor.author | de Bono, JS | |
dc.contributor.author | Efstathiou, E | |
dc.contributor.author | Gravis, G | |
dc.contributor.author | Higano, CS | |
dc.contributor.author | Hussain, M | |
dc.contributor.author | James, N | |
dc.contributor.author | Logothetis, CJ | |
dc.contributor.author | Morgans, A | |
dc.contributor.author | Parker, C | |
dc.contributor.author | Ryan, CJ | |
dc.contributor.author | Saad, F | |
dc.contributor.author | Sartor, O | |
dc.contributor.author | Small, EJ | |
dc.contributor.author | Sternberg, CN | |
dc.contributor.author | Sweeney, CJ | |
dc.contributor.author | Tannock, I | |
dc.contributor.author | Tombal, B | |
dc.contributor.author | Gillessen, S | |
dc.date.accessioned | 2018-02-19T09:03:32Z | |
dc.date.issued | 2017-08-01 | |
dc.identifier.citation | Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 28 (8), pp. 1692 - 1694 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/1236 | |
dc.identifier.eissn | 1569-8041 | |
dc.identifier.doi | 10.1093/annonc/mdx312 | |
dc.format | Print | |
dc.format.extent | 1692 - 1694 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | OXFORD UNIV PRESS | |
dc.subject | ANZUP Consumer Advisory Panel | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Terminology as Topic | |
dc.subject | Prostatic Neoplasms, Castration-Resistant | |
dc.title | Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2017-06-19 | |
rioxxterms.versionofrecord | 10.1093/annonc/mdx312 | |
rioxxterms.licenseref.startdate | 2017-08 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Annals of oncology : official journal of the European Society for Medical Oncology | |
pubs.issue | 8 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Treatment Resistance | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Prostate and Bladder Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Treatment Resistance | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Prostate and Bladder Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 28 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Prostate Cancer Targeted Therapy Group | |
icr.researchteam | Treatment Resistance | |
icr.researchteam | Prostate and Bladder Cancer Research | |
dc.contributor.icrauthor | De Bono, Johann | |
dc.contributor.icrauthor | James, Nicholas | |